PFO Closure Following Tricuspid Valve-in-Valve Implantation

2014 ◽  
Vol 23 (4) ◽  
pp. 385-386
Author(s):  
Stefano Salizzoni ◽  
Fulvio Orzan ◽  
Mauro Rinaldi
2020 ◽  
Vol 21 (6) ◽  
pp. 808-809
Author(s):  
Francesco Melillo ◽  
Luca A. Ferri ◽  
Alessandro Beneduce ◽  
Luca Baldetti ◽  
Marco Ancona ◽  
...  

2016 ◽  
Vol 12 (3) ◽  
pp. 402-402 ◽  
Author(s):  
Maurizio Taramasso ◽  
Fabian Nietlispach ◽  
Danny Dvir ◽  
Pablo Anabitarte ◽  
Igal Moarof ◽  
...  

2017 ◽  
Vol 06 (01) ◽  
pp. e29-e31 ◽  
Author(s):  
Daniel Reichart ◽  
Niklas Schofer ◽  
Florian Deuschl ◽  
Andreas Schaefer ◽  
Stefan Blankenberg ◽  
...  

Background Transcatheter heart valve (THV) therapies have shown to be an alternative to surgical valve replacement, especially in high-risk patients requiring redo surgery. However, reports of transcatheter-based interventions in tricuspid valve position are scarce. Case Description Here, we report a case of successful concomitant transcatheter aortic valve-in-valve (ViV) and tricuspid valve-in-ring (ViR) procedures using a 23-mm CoreValve Evolut R THV (Medtronic, Inc., Minneapolis, Minnesota, United States) in aortic position and a 29-mm SAPIEN3 (Edwards Lifesciences, Inc., Irvine, California, United States) THV in tricuspid position. Conclusion This case demonstrates feasibility of concomitant transcatheter aortic ViV and tricuspid ViR procedures.


2021 ◽  
Vol 9 (11) ◽  
Author(s):  
Mann Chandavimol ◽  
Tawai Ngernsritrakul ◽  
Krissada Meemook ◽  
Sirin Apinyasawat ◽  
Tarinee Tangcharoen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document